{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:13:11Z","timestamp":1771477991396,"version":"3.50.1"},"reference-count":76,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inactivation of the tumor suppressor p53 is essential for unrestrained growth of cancers. However, only 11% of hematological malignancies have mutant p53. Mechanisms that cause wild-type p53 dysfunction and promote leukemia are inadequately deciphered. The stem cell protein Asrij\/OCIAD1 is misexpressed in several human hematological malignancies and implicated in the p53 pathway and DNA damage response. However, Asrij function in vertebrate hematopoiesis remains unknown. We generated the first asrij null (knockout [KO]) mice and show that they are viable and fertile with no gross abnormalities. However, by 6 months, they exhibit increased peripheral blood cell counts, splenomegaly, and an expansion of bone marrow hematopoietic stem cells (HSCs) with higher myeloid output. HSCs lacking Asrij are less quiescent and more proliferative with higher repopulation potential as observed from serial transplantation studies. However, stressing KO mice with sublethal \u03b3 irradiation or multiple injections of 5-fluorouracil results in reduced survival and rapid depletion of hematopoietic stem\/progenitor cells (HSPCs) by driving them into proliferative exhaustion. Molecular and biochemical analyses revealed increased polyubiquitinated protein levels, Akt\/STAT5 activation and COP9 signalosome subunit 5 (CSN5)-mediated p53 ubiquitination, and degradation in KO HSPCs. Further, we show that Asrij sequesters CSN5 via its conserved OCIA domain, thereby preventing p53 degradation. In agreement, Nutlin-3 treatment of KO mice restored p53 levels and reduced high HSPC frequencies. Thus, we provide a new mouse model resembling myeloproliferative disease and identify a posttranslational regulator of wild-type p53 essential for maintaining HSC quiescence that could be a potential target for pharmacological intervention.<\/jats:p>","DOI":"10.1182\/blood.2019000530","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T17:06:08Z","timestamp":1554483968000},"page":"2385-2400","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Asrij\/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence"],"prefix":"10.1182","volume":"133","author":[{"given":"Saloni","family":"Sinha","sequence":"first","affiliation":[{"name":"Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tirath Raj","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roja","family":"Yengkhom","sequence":"additional","affiliation":[{"name":"Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Anudeep","family":"Bheemsetty","sequence":"additional","affiliation":[{"name":"Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Abe","sequence":"additional","affiliation":[{"name":"Genetic Engineering Team and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kiyonari","sequence":"additional","affiliation":[{"name":"Genetic Engineering Team and"},{"name":"Animal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"VijayRaghavan","sequence":"additional","affiliation":[{"name":"National Centre for Biological Sciences, Bangalore, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8243-2821","authenticated-orcid":false,"given":"Maneesha S.","family":"Inamdar","sequence":"additional","affiliation":[{"name":"Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India;"},{"name":"Institute for Stem Cell Biology and Regenerative Medicine, Gandhi Krishi Vignana Kendra, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021109304485400_B1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2017.00265","article-title":"Inflammatory signaling pathways in preleukemic and leukemic stem cells","volume":"7","author":"Hemmati","year":"2017","journal-title":"Front Oncol"},{"issue":"5","key":"2020021109304485400_B2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.hoc.2017.06.012","article-title":"Hematopoietic stem cell approaches to cancer","volume":"31","author":"Adair","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2020021109304485400_B3","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.3390\/ijms18010151","article-title":"Bone niches, hematopoietic stem cells, and vessel formation","volume":"18","author":"Tamma","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2020021109304485400_B4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood-2015-07-607945","article-title":"Hematopoietic stem\/progenitor cell commitment to the megakaryocyte lineage","volume":"127","author":"Woolthuis","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020021109304485400_B5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nri3433","article-title":"The ageing haematopoietic stem cell compartment","volume":"13","author":"Geiger","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2020021109304485400_B6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2016.11.002","article-title":"Molecular mechanisms underlying lineage bias in aging hematopoiesis","volume":"54","author":"Elias","year":"2017","journal-title":"Semin Hematol"},{"issue":"10","key":"2020021109304485400_B7","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1371\/journal.pbio.0020301","article-title":"Molecular signatures of proliferation and quiescence in hematopoietic stem cells","volume":"2","author":"Venezia","year":"2004","journal-title":"PLoS Biol"},{"issue":"3","key":"2020021109304485400_B8","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pgen.0010028","article-title":"Differential expression of novel potential regulators in hematopoietic stem cells","volume":"1","author":"Forsberg","year":"2005","journal-title":"PLoS Genet"},{"issue":"26","key":"2020021109304485400_B9","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1182\/blood-2012-05-356014","article-title":"The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans","volume":"120","author":"Pant","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2020021109304485400_B10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"issue":"9","key":"2020021109304485400_B11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/jcp.22561","article-title":"The p53 tumor suppressor protein regulates hematopoietic stem cell fate","volume":"226","author":"Asai","year":"2011","journal-title":"J Cell Physiol"},{"issue":"6","key":"2020021109304485400_B12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"issue":"9","key":"2020021109304485400_B13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"issue":"6","key":"2020021109304485400_B14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood-2017-02-763086","article-title":"Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy","volume":"130","author":"Prokocimer","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2020021109304485400_B15","doi-asserted-by":"crossref","first-page":"a000950","DOI":"10.1101\/cshperspect.a000950","article-title":"Posttranslational modification of p53: cooperative integrators of function","volume":"1","author":"Meek","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2020021109304485400_B16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"9","key":"2020021109304485400_B17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"D1","key":"2020021109304485400_B18","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","article-title":"BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis","volume":"44","author":"Bagger","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"2020021109304485400_B19","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1080\/15384101.2017.1361064","article-title":"p53 binding sites in normal and cancer cells are characterized by distinct chromatin context","volume":"16","author":"Bao","year":"2017","journal-title":"Cell Cycle"},{"issue":"10","key":"2020021109304485400_B20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb2579","article-title":"Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass","volume":"14","author":"Povlsen","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2020021109304485400_B21","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/s41598-018-25667-3","article-title":"A double helical motif in OCIAD2 is essential for its localization, interactions and STAT3 activation","volume":"8","author":"Sinha","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"2020021109304485400_B22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/dvdy.10332","article-title":"Embryonic stem cell and tissue-specific expression of a novel conserved gene, asrij","volume":"227","author":"Mukhopadhyay","year":"2003","journal-title":"Dev Dyn"},{"issue":"4","key":"2020021109304485400_B23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.celrep.2013.07.029","article-title":"Conserved regulation of the Jak\/STAT pathway by the endosomal protein asrij maintains stem cell potency","volume":"4","author":"Sinha","year":"2013","journal-title":"Cell Reports"},{"issue":"11","key":"2020021109304485400_B24","doi-asserted-by":"crossref","first-page":"e27667","DOI":"10.1371\/journal.pone.0027667","article-title":"Asrij maintains the stem cell niche and controls differentiation during Drosophila lymph gland hematopoiesis [published correction appears in PLoS One. 2012;7(4)]","volume":"6","author":"Kulkarni","year":"2011","journal-title":"PLoS One"},{"issue":"24","key":"2020021109304485400_B25","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","article-title":"A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells","volume":"23","author":"Schwenk","year":"1995","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2020021109304485400_B26","doi-asserted-by":"crossref","first-page":"e0124661","DOI":"10.1371\/journal.pone.0124661","article-title":"hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells","volume":"10","author":"Siegemund","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"2020021109304485400_B27","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1182\/blood-2016-05-716480","article-title":"A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation","volume":"128","author":"Nestorowa","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2020021109304485400_B28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy","volume":"99","author":"Bibi","year":"2014","journal-title":"Haematologica"},{"issue":"7011","key":"2020021109304485400_B29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature02989","article-title":"Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells","volume":"431","author":"Ito","year":"2004","journal-title":"Nature"},{"issue":"7110","key":"2020021109304485400_B30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature05159","article-title":"Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a","volume":"443","author":"Janzen","year":"2006","journal-title":"Nature"},{"issue":"5","key":"2020021109304485400_B31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ncb2468","article-title":"The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells","volume":"14","author":"Maryanovich","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"20","key":"2020021109304485400_B32","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood-2013-07-515619","article-title":"Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner","volume":"123","author":"Shao","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2020021109304485400_B33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cell.2014.08.033","article-title":"A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"issue":"5","key":"2020021109304485400_B34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.2011.08962.x","article-title":"Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes","volume":"156","author":"Del Giudice","year":"2012","journal-title":"Br J Haematol"},{"issue":"7192","key":"2020021109304485400_B35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature06869","article-title":"Long-term haematopoietic reconstitution by Trp53-\/-p16Ink4a-\/-p19Arf-\/- multipotent progenitors","volume":"453","author":"Akala","year":"2008","journal-title":"Nature"},{"issue":"10","key":"2020021109304485400_B36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.exphem.2008.04.012","article-title":"Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice","volume":"36","author":"Chen","year":"2008","journal-title":"Exp Hematol"},{"issue":"1","key":"2020021109304485400_B37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2008.11.006","article-title":"p53 regulates hematopoietic stem cell quiescence","volume":"4","author":"Liu","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2020021109304485400_B38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0301-472X(03)00072-9","article-title":"Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice","volume":"31","author":"TeKippe","year":"2003","journal-title":"Exp Hematol"},{"issue":"5","key":"2020021109304485400_B39","doi-asserted-by":"crossref","first-page":"a026070","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-damage-repair Process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"16","key":"2020021109304485400_B40","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1101\/gad.247452.114","article-title":"Limiting the power of p53 through the ubiquitin proteasome pathway","volume":"28","author":"Pant","year":"2014","journal-title":"Genes Dev"},{"issue":"11","key":"2020021109304485400_B41","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/sj.onc.1207411","article-title":"Regulating the p53 system through ubiquitination","volume":"23","author":"Yang","year":"2004","journal-title":"Oncogene"},{"issue":"43","key":"2020021109304485400_B42","doi-asserted-by":"crossref","first-page":"29011","DOI":"10.1074\/jbc.M804539200","article-title":"Stable form of JAB1 enhances proliferation and maintenance of hematopoietic progenitors","volume":"283","author":"Mori","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"2020021109304485400_B43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.cellbio.19.111301.112449","article-title":"The COP9 signalosome","volume":"19","author":"Wei","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1-3","key":"2020021109304485400_B44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbamcr.2004.09.023","article-title":"The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development","volume":"1695","author":"Schwechheimer","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2020021109304485400_B45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tcb.2003.08.002","article-title":"The COP9 signalosome: an alternative lid for the 26S proteasome?","volume":"13","author":"Li","year":"2003","journal-title":"Trends Cell Biol"},{"issue":"7","key":"2020021109304485400_B46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/emboj\/20.7.1630","article-title":"COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system","volume":"20","author":"Bech-Otschir","year":"2001","journal-title":"EMBO J"},{"issue":"4","key":"2020021109304485400_B47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jcb.21504","article-title":"Roles for CSN5 in control of p53\/MDM2 activities","volume":"103","author":"Zhang","year":"2008","journal-title":"J Cell Biochem"},{"issue":"7-8","key":"2020021109304485400_B48","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.biocel.2007.03.022","article-title":"MDM2 and MDM4: p53 regulators as targets in anticancer therapy","volume":"39","author":"Toledo","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"2020021109304485400_B49","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1074\/jbc.M104431200","article-title":"The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1\/CSN5 and the COP9 signalosome complex","volume":"277","author":"Tomoda","year":"2002","journal-title":"J Biol Chem"},{"issue":"13","key":"2020021109304485400_B50","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1073\/pnas.1303559111","article-title":"ARF1-GTP regulates Asrij to provide endocytic control of Drosophila blood cell homeostasis","volume":"111","author":"Khadilkar","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2020021109304485400_B51","doi-asserted-by":"crossref","first-page":"e18588","DOI":"10.1371\/journal.pone.0018588","article-title":"Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme","volume":"6","author":"Villalonga-Planells","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"2020021109304485400_B52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molmed.2016.06.003","article-title":"Aging, clonality, and rejuvenation of hematopoietic stem cells","volume":"22","author":"Akunuru","year":"2016","journal-title":"Trends Mol Med"},{"issue":"3","key":"2020021109304485400_B53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gpb.2016.04.002","article-title":"DNA damage response in hematopoietic stem cell ageing","volume":"14","author":"Li","year":"2016","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"19","key":"2020021109304485400_B54","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.4161\/cc.8.19.9627","article-title":"The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"issue":"1","key":"2020021109304485400_B55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20042541","article-title":"Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis","volume":"202","author":"Kato","year":"2005","journal-title":"J Exp Med"},{"key":"2020021109304485400_B56","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.2147\/IJN.S101285","article-title":"Upregulation of Akt\/NF-\u03baB-regulated inflammation and Akt\/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle","volume":"11","author":"Tang","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"2020021109304485400_B57","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"2020021109304485400_B58","doi-asserted-by":"crossref","first-page":"e82127","DOI":"10.1371\/journal.pone.0082127","article-title":"Inflammation regulates TMPRSS6 expression via STAT5","volume":"8","author":"Meynard","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2020021109304485400_B59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2020021109304485400_B60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood-2012-10-460618","article-title":"Runx3 deficiency results in myeloproliferative disorder in aged mice","volume":"122","author":"Wang","year":"2013","journal-title":"Blood"},{"issue":"41","key":"2020021109304485400_B61","doi-asserted-by":"crossref","first-page":"43013","DOI":"10.1074\/jbc.M406559200","article-title":"Multiple functions of Jab1 are required for early embryonic development and growth potential in mice","volume":"279","author":"Tomoda","year":"2004","journal-title":"J Biol Chem"},{"issue":"6810","key":"2020021109304485400_B62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"3","key":"2020021109304485400_B63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"issue":"Pt 15","key":"2020021109304485400_B64","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1242\/jcs.064501","article-title":"p53 at a glance","volume":"123","author":"Brady","year":"2010","journal-title":"J Cell Sci"},{"issue":"1","key":"2020021109304485400_B65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"p53 mutations in cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2020021109304485400_B66","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V89.6.2015","article-title":"p53 abnormalities in B-cell prolymphocytic leukemia","volume":"89","author":"Lens","year":"1997","journal-title":"Blood"},{"issue":"11","key":"2020021109304485400_B67","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V97.11.3589","article-title":"FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia","volume":"97","author":"Stirewalt","year":"2001","journal-title":"Blood"},{"issue":"3-4","key":"2020021109304485400_B68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10428199509056825","article-title":"P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance","volume":"17","author":"Newcomb","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2020021109304485400_B69","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"issue":"16","key":"2020021109304485400_B70","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.18632\/oncotarget.7241","article-title":"Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature","volume":"7","author":"Lionetti","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"2020021109304485400_B71","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/sj.leu.2402647","article-title":"Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene","volume":"16","author":"Durland-Busbice","year":"2002","journal-title":"Leukemia"},{"issue":"2","key":"2020021109304485400_B72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"2020021109304485400_B73","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"2020021109304485400_B74","doi-asserted-by":"crossref","first-page":"e2560","DOI":"10.1038\/cddis.2016.430","article-title":"Phosphorylated STAT5 regulates p53 expression via BRCA1\/BARD1-NPM1 and MDM2","volume":"7","author":"Ren","year":"2016","journal-title":"Cell Death Dis"},{"issue":"Database issue","key":"2020021109304485400_B75","doi-asserted-by":"crossref","first-page":"D1117","DOI":"10.1093\/nar\/gku895","article-title":"CODEX: a next-generation sequencing experiment database for the haematopoietic and embryonic stem cell communities","volume":"43","author":"S\u00e1nchez-Castillo","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2020021109304485400_B76","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/22\/2385\/1553555\/bloodbld2019000530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/22\/2385\/1553555\/bloodbld2019000530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T10:17:41Z","timestamp":1581416261000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/133\/22\/2385\/273888\/AsrijOCIAD1-suppresses-CSN5mediated-p53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":76,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,5,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000530","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]}}}